Section 3644, Dialysis for End Stage Renal Disease (ESRD) – General
Guidance for Section 3644, Dialysis for End Stage Renal Disease (ESRD) – General, that has been revised to provide coverage, billing and payment instructions for iron sucrose injection as a first line treatment of iron deficiency anemia when furnished intravenously to patients undergoing chronic hemodialysis who are receiving supplemental erythropoietin therapy.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: June 01, 2001
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.